<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Decreased skeletal muscle <z:chebi fb="105" ids="17234">glucose</z:chebi> disposal and increased endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production (EGP) contribute to <z:hpo ids='HP_0011998'>postprandial hyperglycemia</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, but the contribution of hepatic <z:chebi fb="15" ids="28087">glycogen</z:chebi> metabolism remains uncertain </plain></SENT>
<SENT sid="1" pm="."><plain>Hepatic <z:chebi fb="15" ids="28087">glycogen</z:chebi> metabolism and EGP were monitored in type 2 diabetic patients and nondiabetic volunteer control subjects (CON) after mixed meal ingestion and during hyperglycemic-hyperinsulinemic-somatostatin clamps applying <z:chebi fb="18" ids="36928">13C</z:chebi> nuclear magnetic resonance spectroscopy (NMRS) and variable infusion dual-tracer technique </plain></SENT>
<SENT sid="2" pm="."><plain>Hepatocellular <z:chebi fb="23" ids="18059">lipid</z:chebi> (HCL) content was quantified by 1H NMRS </plain></SENT>
<SENT sid="3" pm="."><plain>Before dinner, hepatic <z:chebi fb="15" ids="28087">glycogen</z:chebi> was lower in type 2 diabetic patients (227 +/- 6 vs. CON: 275 +/- 10 mmol/l liver, P &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>After meal ingestion, net synthetic rates were 0.76 +/- 0.16 (type 2 diabetic patients) and 1.36 +/- 0.15 mg x kg(-1) x min(-1) (CON, P &lt; 0.02), resulting in peak concentrations of 283 +/- 15 and 360 +/- 11 mmol/l liver </plain></SENT>
<SENT sid="5" pm="."><plain>Postprandial rates of EGP were approximately 0.3 mg x kg(-1) x min(-1) (30-170 min; P &lt; 0.05 vs. CON) higher in type 2 diabetic patients </plain></SENT>
<SENT sid="6" pm="."><plain>Under clamp conditions, type 2 diabetic patients featured approximately 54% lower (P &lt; 0.03) net hepatic <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthesis and approximately 0.5 mg x kg(-1) x min(-1) higher (P &lt; 0.02) EGP </plain></SENT>
<SENT sid="7" pm="."><plain>Hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> storage negatively correlated with HCL content (R = -0.602, P &lt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>Type 2 diabetic patients exhibit 1) reduction of postprandial hepatic <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthesis, 2) temporarily impaired suppression of EGP, and 3) no normalization of these defects by controlled hyperglycemic <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, impaired insulin sensitivity and/or <z:hpo ids='HP_0011010'>chronic</z:hpo> glucolipotoxicity in addition to the effects of an altered insulin-to-glucagon ratio or increased free fatty acids accounts for defective hepatic <z:chebi fb="15" ids="28087">glycogen</z:chebi> metabolism in type 2 diabetic patients </plain></SENT>
</text></document>